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Abstract 
Ageing is the greatest risk factor for cardiovascular disease. Calcium/calmodulin dependent protein 
kinase II (CaMKII) plays a fundamental role in the pathology of heart disease yet a potential role for 
CaMKII in cardiovascular pathology associated with ageing remains unclear. Taking a combined in vivo 
and in vitro approach, we have for the first time investigated whether CaMKII expression and CaMKII 
activity may be altered following age-related cardiovascular deterioration. Both cardiac contractility and 
aortic blood flow are compromised in aged rats and we have shown that this occurs in parallel with 
increased inflammation and crucially, autonomous activation of CaMKII. Endothelial cells isolated from 
young and aged aortae exhibit differences in cell phenotype and physiology. In line with observations in 
aortic tissue, aged aortic endothelial cells also show increased basal levels of pro-inflammatory markers 
and oxidative stress with concurrent increased basal activation of CaMKII. These results are the first to 
demonstrate that elevated CaMKIIexpression andCaMKII activation occur in parallel with the 
pathological progression associated with ageing of the heart and vasculature. Specifically, 
CaMKIIexpression is significantly increased and activated in the endothelium of aged aorta. As such, 
CaMKII could serve as an important marker of endothelial dysfunction that accompanies the ageing 
process and may be an appropriate candidate for investigating targeted therapeutic intervention. 
Key words: Ageing, Cardiovascular, Endothelium, Calcium/calmodulin protein kinase II, Inflammation, 
Oxidative stress 
Abbreviations: CaMKII, calcium/calmodulin dependent protein kinase II; EC, endothelial cell; ED, 
endothelial dysfunction; ROS, reactive oxygen species; NFB, nuclear factor kappa B 
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1. Introduction 
Cardiovascular ageing is a complex and dynamic process involving not only changes to the heart muscle 
but also significant adaptations to the vasculature. A crucial feature of the aged vasculature is the 
development of endothelial dysfunction (ED), where a chronically ‘activated’ phenotype is adopted 
within the endothelium contributing to impaired vascular function [1]. Enhanced endothelial permeability 
and leukocyte adhesion is evident in the aged vasculature and it has been proposed that a chronic low 
grade inflammatory phenotype is evident in older people, significantly increasing the risk of illness and/or 
death [2]. The pathogenesis of ED associated with ageing is also mediated by reactive oxygen species 
(ROS). ROS, in particular superoxide (O2
-) and hydrogen peroxide (H2O2), are known to be significantly 
elevated in aged individuals. They act to reduce the bioavailability of the endothelium-derived relaxing 
factor nitric oxide (NO), contributing to impaired endothelium dependent dilation (EDD) and this is often 
considered the first sign of adverse cardiovascular events [3,4]. ROS also play a role in activating various 
signal transduction pathways within vascular cells mediating the production of pro-inflammatory 
transcription factors such as Nuclear Factor kappa B (NF-κB) [2]. It is now generally accepted that both 
inflammation and oxidative stress work in parallel contributing to age-associated cardiovascular 
dysfunction. To date, there have been a variety of molecular mechanisms identified that may mediate 
endothelial dysfunction [5] however, the contribution of these pathways to both cardiac and vascular 
dysfunction remains uncertain. 
Previous work has established that the multifunctional enzyme CaMKII is activated under conditions of 
increased oxidative stress (via methionine 281/282 oxidation) and inflammation in the heart [6,7]. 
CaMKII is encoded by four different genes (and) with CaMKII being the major isoform 
expressed in heart. A direct link between the autonomously active enzyme and enhanced myocardial 
dysfunction has been well documented in numerous animal models of heart disease as well as in human 
hearts [8-10]. Indeed, such is the wealth of evidence for the pivotal role that CaMKII plays in heart 
disease, there is growing confidence that targeting this enzyme could be an important advance in the 
treatment of heart disease [11-13]. It remains to be established whether CaMKII activation is observed 
during progressive cardiovascular dysfunction associated with ageing. Given the link between cardiac 
ageing and disease, this seems likely. It also seems possible that a similar relationship may exist in the 
vasculature however, much less is known of the role CaMKII plays in this environment. Several groups 
have reported that CaMKII signalling may contribute to vascular pathologies, such as atherosclerosis. 
This has primarily been shown in arterial smooth muscle cells (SMCs), where CaMKII has been 
identified as playing a key role in SMC proliferation, hypertrophy, migration and contraction [14-17]. It 
has been documented that both δ and  isoforms of CaMKII are expressed in vascular smooth muscle and 
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endothelial cells [18]. However, more recently, studies in human umbilical vein endothelial cells have 
suggested that the δ isoform is prevalent in endothelium, specifically CaMKII6 [19]. This potential 
predominance of the isoform in the vascular endothelium is similar to what is observed in the heart. 
There is also some limited evidence that CaMKII may be important in pathophysiological signalling in 
endothelial cells where modulation of endothelial nitric oxide synthase (eNOS) could also underlie 
CaMKII contribution to atherogenesis [19,20]. However, currently nothing is known of whether 
endothelial CaMKII may exhibit sustained activation that could contribute to vascular dysfunction during 
the ageing process.  
Here, we have taken both in vivo and in vitro approaches to compare the heart and vasculature (the aorta) 
between young and aged animals. We have assessed both heart and aorta function and have examined the 
status of CaMKII activation in both. We have confirmed both cardiac dysfunction and elevated blood 
flow in aged animals along with parallel increases in inflammation and oxidative stress. Importantly, and 
for the first time, we have shown that CaMKII expression and CaMKII activation are increased in these 
hearts and CaMKII activation is also increased in aortae from aged animals. Specific focus on the 
vascular endothelium has demonstrated that an altered phenotype of endothelial cells isolated from the 
aged aortae corresponds with increased inflammatory status and oxidative stress as well as elevated 
CaMKIIexpression and CaMKII activation in these cells. This work demonstrates for the first time a 
correlation between CaMKIIδ and the pathology accompanying not only the ageing heart, but also the 
ageing vasculature. Given what is already accepted about the principal role CaMKII plays in diseased 
heart, the current work could serve as early evidence highlighting additional potential for this enzyme as a 
useful target for therapeutic intervention in the elderly population.  
 
2. Materials and Methods 
 
2.1 In vivo echocardiography 
All procedures were performed under sterile conditions, complied with the ARRIVE guidelines and 
conformed to the Guide for the Care and Use of Laboratory Animals published by the US National 
Institutes of Health (NIH Publication No. 85-23, revised 1996) and Directive 2010/63/EU of the 
European Parliament. Male Sprague Dawley rats (young (10-12 week) and aged (18-20 month)) were 
briefly anaesthetised in a perspex chamber with 3% Isoflurane in the presence of 100% oxygen at a flow 
rate of 2L/min. After 2-3 minutes, rats were placed supine on a facemask and were maintained with 1.5-
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2% Isoflurane in the presence of 0.5-1L/min oxygen. Fur was removed by application of a topical 
depilatory cream from the neck and upper chest area. For echocardiography of the heart, two-dimensional 
short axis views and M mode images were recorded at the level of the papillary muscle with the use of a 
MIUS HDI 3000CV echocardiography system, a 13MHz linear array transducer and ultrasound 
transmission gel. Systolic and diastolic LV wall measurements (including anterior wall (AW) and 
posterior wall (PW) measurements, LV end systolic dimension (LVESD), LV end diastolic dimension 
(LVEDD) and fractional shortening (%FS)) were assessed from M mode traces. Fractional shortening 
(FS) (%) is expressed as [LVEDD – LVESD/ LVEDD] x 100. An average of three measurements of each 
variable was used for each animal. For measurements of blood flow through the ascending aorta, a short 
axis view of the heart was obtained initially. The probe was then slowly turned ~70-80˚ clockwise to a 
longitudinal axis to allow a clear view of the vessels to be visualised. Brightness mode (B mode) 
ultrasound was used to measure vessel diameter and colour Doppler mode to visualise the direction of 
blood flow. Pulsed wave Doppler mode (PWD) was used to measure the velocity of blood passing 
through the ascending aorta. From these traces, the velocity time integral (VTI) and heart rate (HR) could 
be assessed. At least three measurements were recorded for velocity in the vessel per animal and an 
average taken. The blood flow was then calculated using the following formula: 
 
 
2.2 Preparation of cardiac and aortic homogenates 
Hearts and aortae were dissected immediately following termination by intraperitoneal injection with 
pentobarbital sodium (10µl/g weight of animal; Euthatal) and heparin (0.1µl/g weight of animal; 5000 
units/ml). Tissues were washed briefly in ice cold Ca2+-free Krebs solution (120mM NaCl, 5.4mM KCl, 
0.52mM NaH2PO4, 20mM Hepes, 11.1mM glucose, 3.5mM MgCl2, 20mM taurine, 10mM creatine, pH 
7.4). Cardiac ventricular tissue was finely minced on ice and whole tissue homogenates prepared as 
previously described [21]. Aortae were pulverised in liquid nitrogen using a mortar and pestle, until a fine 
white powder was formed. The frozen vessel was then solubilised by adding 10 volumes (W/V) of 
solubilisation buffer (50mM Tris pH 7.5, 50mM NaCl, 1% glycerol, 1mM EDTA, 1mM DTT, 1% Triton 
X, 1x protease inhibitors (Merck), 1 x phosphatase inhibitors (Merck)). This was left to mix end-over-end 
for 10 min at 4˚C before centrifugation at 13,000g for 5 min, also at 4˚C. The supernatant was then 
removed and used for subsequent experiments described below. 
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2.3 Isolation of rat aortic endothelial cells 
The thoracic aorta was rapidly removed from rats following termination as described above. The vessel 
was flushed gently with warmed Ca2+-free Krebs and any surrounding tissue was excised. A small clamp 
was used at one end of the vessel to close the opening of the lumen. Using a 19G needle, warmed Ca2+-
free Krebs solution containing 2mg/ml collagenase Type II (Worthington Chemicals, U.K.) was flushed 
inside the vessel. Another clamp was used to close the opening of the lumen at the opposite end, allowing 
only the inner endothelial lining of the aorta to be exposed to the enzyme for subsequent digestion. The 
collagenase-filled aorta was incubated for 10 min at 37˚C in an atmosphere of 5% CO2. Following 
digestion, both clamps were removed and 5ml of culture media consisting of Dulbecco’s Modified Eagle 
Medium (DMEM) supplemented with 20% (v/v) foetal calf serum (FCS), 1% (v/v), L-Glutamine and 2% 
Penicillin/ Streptomycin was added to the culture dish. Cells were separated by centrifugation at 1200g 
for 5 min before re-suspending the cell pellet in 5ml fresh culture media. This was then plated in a T25 
flask and incubated at 37˚C in an atmosphere of 5% CO2 for 4h. After this time, remaining smooth muscle 
cells and fibroblasts were removed by replacement with endothelial cell specific Medium G (20% FCS, 
1000U/ml Penicillin-G, 100µg/ml Streptomycin, 2mM L-Glutamine, 1 x non-essential amino acids 
(GIBCO), 1 x sodium pyruvate (GIBCO), 25mM HEPES (pH 7 – 7.6, 100µg/ml heparin, 60µg/ml 
endothelial cell growth supplement (ECGS) (Sigma-Aldrich)) and endothelial cells grown to 60-80% 
confluency.  
 
2.4 Haematoxylin and Eosin staining 
Animals were euthanised as described above and aortae rapidly excised and washed thoroughly in ice 
cold Ca2+-free Krebs solution. Tissue was fixed in 10% formaldehyde for 24h before being processed, 
embedded in paraffin wax and sectioned (5µm). Tissue sections were rehydrated then stained in 
haematoxylin for 6 min followed by eosin for 1 min. Slides were then dehydrated and mounted on 
coverslips before imaging. Five random sections per aorta sample and five areas of interest per sample 
were photographed at 10x magnification using a Leica DFC 320 camera (Leica Microsystems, Germany). 
Mean vessel width (µm) were then calculated from these images. 
 
2.5 CD45 positive staining 
Infiltration of leukocytes was assessed in fixed (10% formaldehyde), paraffin-embedded LV and aortic 
sections (5µm) with an anti-CD45 rat polyclonal antibody (1:250; BD BioSciences, Oxford, U.K.) using 
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diaminobenzidine (DAB) as the chromagen and Haematoxylin to counterstain. Five random sections per 
sample and five areas of interest per section were photographed at 40x magnification using a Leica DFC 
320 camera (Leica Microsystems, Germany). Quantification was performed on Image J software, where 
the percentage of positive staining within a field of view was calculated. 
 
2.6 TNF-α ELISA 
Blood serum samples were collected from young and aged animals following cardiac puncture after 
euthanasia. Concentrations of TNF-α were determined using a commercially available ELISA kit 
following manufacturer’s instructions (ELISA Ready-SET-Go! ®, eBioscience). Plates were read at 
450nm using a BioTek EPOCH plate reader and Gen5 software. Standards were plotted using log-log 
linear fit and samples with absorbance readings falling within the linear range of the curve were 
quantified.  
 
2.7 Detection of intracellular ROS 
Young and aged cells were plated in a black-sided 96 well plate at 25,000 cells/well and allowed to attach 
overnight. Cells were then washed once with HBSS and stained with 25µM 2’, 7’-dichlorofluorescein 
diacetate (DCFDA) (Abcam, Cambridge, MA) in HBSS for 45 minutes in the dark at 37°C. Cells were 
washed once with HBSS and treated with/without Ang-II for 3h in supplemented buffer (10% FCS (v/v) 
diluted in HBSS). 50µM Tert-Butyl Hydrogen peroxide (TBHP) was used as a positive control for the 
assay. Fluorescence was measured at 485nm excitation/535 emission. 
 
2.8 CaMKII activity assay 
CaMKII activity was assessed by measuring phosphorylation of a specific peptide substrate (autocamtide-
2 (KKALRRQETVDAL)) by the transfer of phosphate of [-32P]ATP by CaMKII. Assay components 
comprised Assay Dilution Buffer (ADB) (20mM MOPS, pH 7.2, 25mM -glycerophosphate, 1mM 
Na3VO4, 1mM DTT, 1mM CaCl2), Mg/ATP cocktail (75mM MgCl2, 500M ATP in 20mM MOPS, pH 
7.2, 25mM -glycerophosphate, 5mM EGTA, 1mM Na3VO4, 1mM DTT), CaMKII substrate cocktail 
(500M autocamtide II (Merck) and 40g/ml calmodulin in ADB) and PKA/PKC inhibitor cocktail 
(2M PKA inhibitor peptide (Merck) and 2M PKC inhibitor peptide (Merck) in ADB). Assay 
components were mixed on ice to a total volume of 40l comprising 10l ADB, 10l substrate cocktail, 
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10l inhibitor cocktail and 10l CaMKII source (recombinant protein (Merck) or aorta homogenate) 
diluted to required concentration in ADB. Reactions were initiated by addition of 10l [-32P]ATP diluted 
to 1Ci/l with Mg/ATP cocktail. Each sample was assayed in triplicate and incubated for 10 min at 
30oC with constant agitation. Following incubation, reactions were terminated by spotting 25l on to P81 
phosphocellulose paper. These were then washed in 0.75% phosphoric acid followed by acetone before 
counting in a scintillation counter. Specific radioactivity of the Mg/ATP cocktail was determined by 
counting 5l directly and background counts were determined from samples in which the CaMKII source 
was absent. 
 
2.9 Immunoblotting 
Young and aged cells were grown on a 12-well plate 48h prior to assay and were solubilised with addition 
of 150µl 1x Laemmli buffer containing 75mM DTT. Samples were loaded onto 10% (v/v) acrylamide 
gels and analysed by SDS-PAGE using the BioRad® system. Following protein transfer to nitrocellulose, 
membranes were blocked in 5% (w/v) non-fat dry milk diluted in TBST buffer (20mM Tris-base, 137mM 
NaCl and 0.1% (v/v) Tween 20, pH 7.6) for 1h at room temperature. Membranes were then incubated 
overnight at 4˚C with antibodies against CaMKIIδ (rabbit polyclonal antibody 1:1000, custom-made 
against the C-terminus of CaMKIIδ (Eurogentec)), phosphorylated (phospho)-CaMKII (mouse 
monoclonal 1:500, Fisher Scientific) or oxidised (ox)-CaMKII (rabbit polyclonal 1:1000, GeneTex) 
prepared in 5% (w/v) BSA in TBST. Membranes were washed and then incubated for 2h at room 
temperature with either goat anti-mouse IgG-HRP (Sigma-Aldrich) or goat anti-rabbit IgG-HRP diluted 
1:5,000 and 1:10,000 respectively. For quantitative analysis, following development membranes were 
stripped and re-probed for GAPDH expression as an internal loading control (mouse monoclonal 
1:40,000 (Abcam). This was followed by addition of anti-mouse IgG-HRP (1:5,000). Scanned 
immunoblots were quantified by densitometry using a GS-800 densitometer and Quantity One Image 
software (version 4.5.2, BioRad) and signals expressed as ratios. 
 
2.10 Immunofluorescence 
Young and aged endothelial cells were grown on coverslips until confluent and fixed by aspirating the 
culture medium and applying ice cold methanol for 10 min. For experiments investigating phospho-NF-
κB p65 (pp65) activation, young cells exposed to 10ng/ml TNFα (10 min) prior to fixation were used as a 
positive control. Cells were then washed 3 times with phosphate buffered saline (PBS) and permeabilised 
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with Triton X-100 (0.01% (v/v)) for 10 min. Non-specific binding was blocked using 1% (w/v) Bovine 
Serum Albumin (BSA) in PBS for 1h at room temperature followed by direct addition of primary 
antibody (CD31/Platelet endothelial cell adhesion molecule (PECAM)-1, 1:100; von Willebrand Factor 
(vWF), 1:100 (mouse monoclonal, Abcam); CaMKIIδ, 1:50; ox-CaMKII, 1:50 and pp65, 1:100 (rabbit 
polyclonal, Cell Signalling)), all prepared in 1% (w/v) BSA in sterile PBS and incubated overnight at 
4˚C. Anti-rabbit IgG-TRITC and anti-mouse IgG-FITC  conjugated secondary antibodies (Molecular 
Probes) were then applied at a 1:200 dilution for 1h at room temperature. After washing, coverslips were 
mounted using Mowiol® mounting medium containing DAPI (Vecta laboratory) and stored at 4˚C in the 
dark until they were viewed and photographed. The DAPI-counter stain in the mounting medium stained 
the cell nuclei blue. Pictures were taken using Nikon EclipseTM E600 Oil Immersion microscope 
connected to photometrics (CoolSnapTM Fx) digital camera managed by MetaMorphTM software 
(Universal Imaging Corporation, West Chester, PA). 
 
2.11 Statistical Analysis 
Data are expressed as mean ± SEM of n observations, where n represents the number of animals or 
samples. Statistical comparisons were performed using Student’s unpaired t test, one- or two-way 
ANOVA followed by the appropriate post-test as indicated. Values of p<0.05 were considered 
statistically significant.  
 
3. Results 
3.1 In vivo measurements of cardiac and vascular function in young and aged rats 
Short-axis views of the left ventricle in young and aged rats (Fig. 1A(i) and (iii)) were used to monitor 
cardiac contractility and M-mode traces (Fig. 1A(ii) and (iv)) measured to determine FS (%) for both age 
groups. There was a significant decrease in FS in aged animals when compared with young (Fig. 1B(i)) 
(63.2±1.3 vs. 50.6±1.9, young vs. aged, p=0.005, n=8) indicating compromised contractile function in 
aged hearts. In line with the observed decrease in FS, there was also a significant decrease in heart rate 
(HR) (bpm) in aged animals (Fig. 1B(ii)) (334±13 vs. 271±6, young vs. aged, p=0.006, n=11). 
Furthermore, there was a significant increase in heart size reflected as increased heart weight:body weight 
ratio (HW/BW) in the aged group (2.68±0.2 vs. 3.63±0.1, young vs. aged, p=0.04, n=11).  
As well as cardiac dysfunction, ageing is associated with vascular dysfunction. Fig. 2A shows the 
functional changes in aortic blood flow that accompany ageing. Long axis views of young and aged 
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aortae are shown in Fig 2A (i) and (ii) respectively. PWD was used to measure the speed with which the 
pressure wave travels along the vessel. Overall, blood flow (ml/min) was faster in aged vessels (velocity 
peaks are higher as shown in Fig. 2A(iv) compared with young vessels (Fig. 2A (iii)) (76.7±4 vs. 
104±9.7, young vs. aged, p=0.05, n=9) and there was more turbulence, reflected in the spread of 
normalised flow measurements (Fig. 2A(v)). In line with altered blood flow, the physiology of the aorta 
was also altered in aged animals. The overall size and lumen of the vessel was larger in aged animals 
(Fig. 2B(i)) and aged vessels showed increased medial wall thickness (16.4±0.9 vs. 28±1.5 (m), young 
vs. aged, p=0.003, n=9) (Fig. 2B(ii)).  
 
3.2 Quantification of CaMKII expression and CaMKII activation in heart and aorta of young and aged 
animals 
Following in vivo echocardiographic assessment of cardiovascular function, cardiac and aortic tissue 
from aged animals were processed for immunoblotting as described in the methods section. As shown in 
Fig 3A(i) and (ii) CaMKIIexpression was significantly increased in aged heart 
((Ca:GAPDH).03±0.04 vs. 1.71±0.26, young vs. aged, p=0.03, n=7). Using site-specific 
antibodies generated against the phospho-Thr 286/287 site and the ox-Met 281/282 site on CaMKII, 
expression levels of both ‘activated’ forms of the enzyme were measured in young and aged hearts. 
Levels of phospho-CaMKII were significantly increased in aged hearts ((pCaMKII:GAPDH) 0.85±0.09 
vs. 1.19±0.12, young vs. aged, p=0.04, n=7) as were levels of ox-CaMKII ((oxCaMKII:GAPDH) 
0.9±0.08 vs. 1.14±0.04, young vs. aged (heart), p=0.03, n=5). Fig 3B (i) and (ii) show the results from 
similar experiments conducted for young and aged aortae. There was no significant difference in 
CaMKII expression observed in the aged aorta (1.03±0.07 vs. 1.26±0.1, young vs. aged, p=0.09, n=7), 
however upon examining each of the variants (individual bands) shown in the blot (Fig. 3B(i)) there 
appeared to be a greater increase in certain variants over others in the aged aorta. A true reflection may 
only come from analysing each variant separately. Levels of both phospho-CaMKII and ox-CaMKII were 
significantly increased in aged aortae compared with young, (pCaMKII:GAPDH)1.16±0.13 vs. 1.82±0.2, 
young vs. aged, p=0.04, n=7 and (oxCaMKII:GAPDH) 1.02±0.01 vs. 1.3±0.07, young vs. aged, p=0.01, 
n=4). To investigate CaMKII activity in aged aorta using an alternative approach, aortic homogenates 
were used as a source of CaMKII to measure incorporation of [32P]ATP into autocamtide II (a CaMKII-
specific peptide substrate) in the presence of PKA and PKC inhibition. Fig 4A shows the specificity of 
the kinase assay using recombinant(r) CaMKII Fig 4A(i) shows total 32P measured for each treatment 
and Fig 4A(ii) specific activity following each treatment where 10ng and 30ng of rCaMKII resulted in 
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activity levels of ~200pmol phosphate incorporated into the autocamtide peptide substrate/min/g 
protein. When the assay is performed with rCaMKII in the absence of substrate or in the absence of 
CaCl2, activity levels fall to close to zero. When the assay is performed without rCaMKII, activity is 
also close to zero. Using the same assay to assess tissue preparations, Fig 4B shows that CaMKII activity 
associated with aortic homogenates from young animals showed no significant difference compared with 
control whereas, activity associated with aged aortae was increased significantly relative to control ((pmol 
PO4
-inc/min) 2.31±0.56 (control no enzyme), 5.95±1.9 (young, p=0.054, n=3), 8.21±1.4 (aged, p=0.03, 
n=3) and this supports the evidence for increased CaMKII activity in aged aortae as assessed by 
phosphorylation and oxidation of CaMKII shown in Fig. 3.  
 
3.3 Measurement of inflammatory markers in young and aged rats 
Initial data examining circulating inflammatory molecules showed that levels of TNF were increased in 
the blood of aged animals when compared with young ((pg/ml) 0.002±0.002 vs. 22.05±12.9, young vs. 
aged, p=0.02, n=4) (Fig. 5A). There was considerable spread in the aged data, reflecting the labile nature 
of TNF and variation across animals. N numbers were low due to availability of blood samples for 
animals in the current study therefore further experiments sought to investigate whether evidence for 
leukocyte infiltration into aged tissues (presumably in response to increased cytokine levels) may be 
apparent in aged heart and aortae. Sections of heart and aorta were examined for expression of CD45 as 
an indicator of leukocyte infiltration. Fig 5B (i) and (ii) show CD45 staining in representative sections of 
left ventricular tissue from young and aged animals respectively and quantification is shown in Fig 5B 
(iii) reflecting an increase in staining in aged heart ((% CD45 positive cells) 3.25±0.2 vs. 14.87±1.7, 
young vs. aged p=0.006, n=6). Fig. 5C (i) and (ii) shows CD45 staining in representative sections of aorta 
from young and aged animals respectively. Fig. 5C (iii) shows the quantification analysis reflecting an 
elevation in CD45 staining in the aortae of aged animals when compared with young but without a 
significant increase ((%CD45 positive cells) 3.02±0.9 vs. 9.7±2.4, young vs. aged p=0.08, n=6). 
 
3.4 Phenotypic alterations in aortic endothelial cells isolated from young and aged aortae 
Having established that aged aortae exhibit significant changes functionally and physiologically and that 
this correlates with a significant increase in CaMKII expression and activation, it was of interest to 
examine this link at the level of the endothelium. Initially, it was important to establish that alterations at 
the level of the aorta were replicated in the endothelial cells (ECs) of these vessels. ECs were isolated 
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from young and aged aortae as described in the methods section. A modified technique (outlined in the 
methods section) was used to obtain high purity yields of cells and resultant cultures were stained for both 
von Willebrand factor (vWF) and PECAM-1 (Fig. 6A). The isolation technique provided EC cultures of 
>95% purity. Cells were isolated from young and aged aortae and kept in culture for up to 8 days with 
growth rate and cell phenotype monitored. Fig 6B shows typical images obtained from both (i) young and 
(ii) aged aortic ECs from day 2 until day 8 post-isolation. Cell growth rate was slower for aged cells (cell 
numbers were consistently fewer following eight days in culture for aged versus young cells) and the 
characteristic EC shape was lost with cells appearing larger, more rounded and stressed (red circles show 
representative cells exhibiting this phenotype). There also appeared to be dark granules or vacuoles in the 
cytoplasm and around the nucleus of aged cells (yellow arrows indicate these granules). Since these were 
not examined in detail, it is difficult to predict what they represent however, it is likely that they are 
associated with cell damage.  
 
3.5 Measurement of pro-inflammatory signalling and oxidative stress in aortic endothelial cells from 
young and aged aorta 
 Phosphorylation (activation) of the pro-inflammatory mediator NFB sub-unit (phospho-p65) was 
monitored in ECs isolated from each either young or aged aortae. Results are shown in Fig. 7A(i) where 
there is a clear increase in the basal phospho-p65 signal in aged cells in the absence of any external 
stimulus. In young cells, there is no obvious basal signal for phospho-p65 (i.e. no obvious inflammatory 
status). To investigate this further, cells from young animals (where there is no basal signal for phospho-
p65) were stimulated with TNF for 10 min prior to staining. There was a significant increase in 
phospho-p65 signal following TNF stimulation of young cells, reflecting the potential for activation of 
this pathway in these cells. Interestingly, the levels of phospho-p65 in young cells following stimulation 
were almost equivalent to levels observed in aged cells without any stimulation ((signal intensity/cell) 
4.75±0.2 vs 22.45±1.3, young vs. aged, p=0.007, n=3 and 4.75±0.2 vs. 23.52±1.1, young vs. young TNFα 
stimulated, p=0.006, n=3) (Fig 7A(ii)). As an additional measure of the stressed phenotype of the aged 
ECs, levels of intracellular ROS were measured and compared in young and aged cells (Fig. 7B). Cell 
permeant DCFDA was used to assess intracellular ROS activity as outlined in the methods section. 
DCFDA is converted to a highly fluorescent compound dichlorofluorescein upon oxidation and can 
therefore be used to quantify total intracellular ROS activity as a fluorescent signal generated in cells 
where ROS activity is present. Under basal conditions, aged ECs had significantly higher levels of 
intracellular ROS than young cells (1556±365 vs. 4065±915 (a.u.), young vs. aged, p=0.03, n=3). To 
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verify that the DCFDA assay could detect changes in intracellular ROS production upon stimulation of 
cells, both groups of cells were also treated with 10M angiotensin II (AngII) for 3h. As would be 
expected, in response to stimulation both young and aged groups showed increased levels of intracellular 
ROS and, interestingly, aged cells still produced significantly higher levels than young cells, reflecting 
what is observed under basal conditions (4856±2754 vs. 8047±2095 (a.u.), young vs. aged, p=0.04, n=3). 
 
3.6 Comparison of CaMKII expression and oxidation in endothelial cells from young and aged aorta 
ECs isolated from young and aged aortae were assessed for CaMKII expression and, given the elevated 
levels of ROS observed in cells from the aged group, for levels of ‘activated’ ox-CaMKII. 
Immunofluorescence experiments showed that both CaMKII (Fig. 8A(i)) and ox-CaMKII (Fig. 8A(ii)) 
were highly expressed under basal conditions in aged cells but there was little, if any, staining evident in 
cells isolated from young aortae. To measure CaMKII and ox-CaMKII in cell populations from both 
young and aged groups, quantitative immunoblotting was used. Interestingly, and in agreement with the 
immunofluorescence data, expression levels of both total CaMKII (Fig. 8B(i)) and ox-CaMKII (Fig. 
8B(ii)) were significantly increased in aged cells when compared with young ((CaMKII:GAPDH) 
0.98±0.14 vs. 1.92±0.33, young vs. aged, p=0.04, n=4 and (ox-CaMKII:GAPDH) 0.85±0.06 vs. 
1.13±0.02, young vs. aged, p=0.007, n=4). 
 
4. Discussion 
The present study is the first to show that CaMKII expression and autonomous CaMKII activation are 
elevated in the heart and the vasculature (aorta) of aged animals. Crucially, this study examined CaMKII 
in parallel with functional output and inflammatory status of these animals. There was evidence for 
significant cardiac and vascular remodelling and compromised function as well as increased inflammation 
as would be anticipated in the aged animal. Specific examination of aortic ECs showed that CaMKII 
expression and oxidised CaMKII were both significantly elevated in aged samples. Importantly, these 
CaMKII measurements were performed in parallel with phenotypic assessment and inflammatory status 
of the aged cells. It is well known that ED is pivotal to the vascular dysfunction that accompanies ageing 
and disease. We have confirmed that aged cells exhibit a stressed phenotype, have elevated pro-
inflammatory signalling and have significantly higher levels of intracellular ROS. In the presence of 
elevated oxidative stress, it is not surprising that CaMKII is oxidised and activated, leading to a myriad of 
pathological effects on the aged vessel. 
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A number of parallels between the aged cardiovascular system and young diseased cardiovascular system 
have already been observed and although ageing itself doesn’t necessarily cause heart failure, there is a 
greater propensity for cardiovascular disease to manifest [22]. It is known that the heart becomes stiffer 
with age as there is increased deposition of fibrous tissue and fat. Cardiac output (CO) declines and 
results in a less efficient response to increased workload. The decrease we observed in the HR of aged 
animals likely reflects physiological changes occurring at the level of the sino-atrial node where there 
may be cell loss and/or dysfunction. Since HR is one of the key factors contributing to CO and with 
ageing there is a reduction in CO, it is not surprising to observe a decline in HR in our aged animals. The 
elevation we observed in blood flow in aged vessels correlates with previous work where aortofemoral 
pulse wave velocity was shown to increase with age and to be a predictor of future cardiovascular events 
[22].  
Findings from the present study provide strong support for CaMKII playing a multi- faceted role 
throughout the cardiovascular system during progression of ageing- induced pathology, and suggest 
CaMKII may not just be a molecular switch for the heart but also for the vasculature in aged individuals. 
Previous work has shown that vascular injury in vivo results in up-regulation of CaMKII in vascular 
smooth muscle (VSM) cells in the medial layer [17]. Indeed, there is significant evidence to suggest that 
elevated CaMKII promotes a synthetic VSM phenotype and regulates proliferation and motility, leading 
to vascular wall remodelling [23]. More recent work has shown that the oxidised form of CaMKII is 
elevated in vivo after vascular injury and in VSM cells following in vitro treatment with agonists that are 
known to increase levels of intracellular ROS [24]. In addition to effects on the VSM cells, CaMKII has 
also been shown to contribute to pathophysiological signalling in ECs [19]. However, as far as we are 
aware, there are no reports to date of the role that CaMKII may play in mediating ED associated with 
ageing. 
The endothelium of the cardiovascular system, although only a single cell layer thick, exhibits an 
extraordinary capacity for modulation of cardiovascular function. It is clear that, like many cell types in 
vivo, the endothelium cannot be viewed as a homogeneous population of cells. In vivo, ECs are 
continually subjected to shear stress from blood flow and this is likely to be different within different 
branches of the vascular tree and will differ according to the health of the individual. Indeed, as we have 
shown in the present study, flow can alter according to age and it is likely that ECs will adapt not only to 
disturbances related to age or disease, but will also adapt to changes along the vascular tree in healthy 
conditions. This may involve changing cell phenotype and alterations in protein expression to 
accommodate the environment [25]. We recognise that cultured ECs do not exactly mimic the in vivo 
situation since they are studied under static conditions without any resident neighbouring VSM cells and 
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may present with a different phenotype from what would be observed in vivo. The key point for the 
present study though is that both groups of ECs (young and aged) have been treated identically yet still 
exhibit significant physiological and biochemical differences and crucially, what we observe in the intact 
aortic tissue (in terms of CaMKII expression and activation) is mirrored in the isolated aortic ECs. 
Interestingly, we observe more significant changes in CaMKII and ox-CaMKII in aged ECs when 
compared with aged aortic tissue. This may reflect the importance of CaMKII in modulation of aged EC 
function although we have not compared with possible changes to CaMKII in other cell types of the 
vasculature in these aged animals.  
It is worth noting that a recent study has provided evidence for increased agonist-evoked endothelial 
calcium signalling in aged carotid arteries [26]. The authors describe this as somewhat of a paradox in a 
situation where decreased endothelial function and eNOS activity is seen. There is an analogy between 
this data and what has been shown in the present study. Increased calcium signalling in the aged 
endothelium could lead to increased CaMKII activation and sustained autonomous CaMKII activity. As 
we know from a wealth of studies in cardiac myocytes, elevated CaMKII activity is only useful up to a 
certain point. There must be a fine balance and control over the switch from basal to sustained activation 
and pathological consequences. This rule could also hold true for the vascular endothelium, where there 
may be potential for increased calcium signalling in aged animals leading to increased CaMKII activation 
and ultimately vascular dysfunction. 
Although we refer to the endothelium as though it were a homogeneous entity, we know this is not the 
case. It is essential that the complexity and heterogeneity of the endothelium is not forgotten, particularly 
in the context of the present study. How apt that a molecule often referred to as a molecular switch in the 
heart, should prove to be significantly switched on in aged aorta, and even more so in aged endothelium. 
CaMKII could serve as an immediate transducer of altered calcium handling along the entire body of the 
endothelium, switching rapidly between resting and activated status in regions of greater stress. It is also 
pertinent that CaMKII sensitivity is increased in damaged and aged VSM cells [27]. Altered CaMKII 
signalling could play a crucial role in the communication between VSM cells and ECs and as such, could 
impact significantly on the dysfunction observed at the level of both cell types during ageing.  
There is still much that remains unknown regarding the mechanisms that underlie cardiovascular 
dysfunction associated with ageing. What is clear from the present study is that CaMKIIa molecule we 
know to be central to cardiac health and disease [28] is activated in synchrony with pro-inflammatory 
pathways and oxidative stress in the aged cardiovasculature. It seems likely that up-regulation and 
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activation of CaMKII will contribute to ED and in that sense, its pathological actions are likely to mirror 
those observed in the contractile cells of the diseased heart [29].  
5. Conclusion 
This study confirms that CaMKII activity and expression of the CaMKII isoform are up-regulated in 
both aged heart and aged aortae. This occurs in parallel with deterioration of cardiovascular function. 
Specific examination of endothelial cells isolated from aged aortae confirms that CaMKII is oxidised and 
activated in line with an increased inflammatory and oxidative stress status in these cells. Future work 
should focus on determining the effects of selective inhibition of CaMKII in the aged endothelium. This 
will be essential for our understanding of how CaMKII may contribute to the local heterogeneous as well 
as to the global more homogeneous, responses of the endothelium in the aged animal.  It will also be 
important to decipher the potential for different delta variants playing specific roles in cellular and sub-
cellular function. With a wealth of increasing evidence now supporting a vital role for CaMKII in both 
cardiac and vascular dysfunction at the level of numerous resident cell types, the argument for 
therapeutics designed towards specific modulation of cardiovascular CaMKII to combat functional 
deficits becomes progressively more convincing.  
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Figure Legends 
Fig. 1 Cardiac hypertrophy and contractile dysfunction is evident in aged rats. (A) Representative 
ultrasound of a two-dimensional short axis view of the heart obtained in (i) young and (iii) aged rats. 
Visualisation of structures including the left ventricle (LV), anterior wall (AW), posterior wall (PW) and 
the papillary muscles (PM) were obtained. M mode traces were recorded at the level of the PM and are 
shown for (ii) young and (iv) aged animals respectively.  These were used to generate systolic and 
diastolic wall measurements: LV end systolic dimension (LVESD) and LV end diastolic dimension 
(LVEDD). Images are representative of n=8 (young) and n=11 (aged) rats. (B) Scatter plots representing 
mean fractional shortening (%) and heart rate values (bpm) in young and aged animals, n=8 for young 
and n=11 for aged rats. (C) Histogram showing mean heart weight:body weight (HW:BW) for young and 
aged rats, n=10 for each group. All data are expressed as mean ± S.E.M and data analysed using a 
student’s unpaired t test, *p<0.05, **p<0.01. 
 
Fig. 2 Blood flow and aortic physiology is altered in aged animals. (A) Representative parasternal long 
axis (PLAX) view of the ascending aorta (AA) obtained in (i) young and (ii) aged rats using ultrasound to 
show LV and aortic valve (AV) structures. For assessing blood flow, a Pulsed Wave Doppler mode was 
used where blood velocity traces could be visualised in (iii) young and (iv) aged animals. All images are 
representative of n=9 for both young and aged rats. (v) Blood flow (ml/min) through the AA was 
calculated using the formula described in the methods section. All values were normalised to AA 
diameter, n=9 for both groups. (B) Histological representation of aortae dissected from young and aged 
rats by H&E staining. The left hand panel shows a section taken from the aorta of a young animal and the 
right hand panel shows a section taken from an aged counterpart. Images are representative of n=3 for 
both groups at 10x magnification (scale bar shown is 500µm). (ii) Histogram showing mean aorta wall 
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thickness in young and aged rats. Values are plotted as mean ± S.E.M and data analysed using a student’s 
unpaired t-test, n=3, **p<0.01. 
Fig. 3 CaMKIIδ expression and activation via phosphorylation and oxidation are increased in aged heart 
and aortae. (A(i)) Representative immunoblots of total CaMKIIδ, phosphoThr286/7 (p)-CaMKII and 
oxMet281/282 (ox)-CaMKII expression in young and aged rat whole heart homogenates (10g loads total 
protein) are shown in addition to expression of the loading control GAPDH. (ii) Densitometry analysis 
was performed and data normalised to GAPDH for each immunoblot. Mean normalised data are shown in 
accompanying histograms for CaMKII n=7, p-CaMKII n=7 and ox-CaMKII n=5, *p<0.05. (B(i)) 
Representative immunoblots of CaMKIIδ, phosphoThr286/7-CaMKII and oxMet281/282 (ox)-CaMKII 
(10g total protein loads) are shown for young and aged whole aortic homogenates together with (ii) 
histograms displaying mean normalised data ± S.E.M. for CaMKII n=7, p-CaMKII n=7, and ox-
CaMKII. Statistical analysis was performed using a student’s unpaired t-test, n=4,*p<0.05.  
 
Fig. 4 Basal CaMKII activity is significantly increased in aortae from aged animals.  (A) Histogram 
showing assay specificity with activity obtained from 10ng and 30ng recombinant CaMKII in (i) counts 
per minute (cpm) as well as (ii) phosphate incorporated into specific autocamtide II peptide substrate/min 
/g protein.  Activity was monitored in the presence of inhibitors to PKA and PKC and in the presence 
and absence of autocamtide substrate (w/o substrate), in the presence or absence of CaCl2 (w/o Ca
2+) and 
in the absence of rCaMKII (w/o CaMKII). Data are from one experiment, representative of two others. 
(B) Histogram showing CaMKII activity (using the same assay) in young and aged whole aortic 
homogenates (10µg total protein) when compared with background activity (no source of enzyme). 
Activity was measured as [32P] incorporated into specific autocamtide II peptide substrate/min/10g 
protein. Data are expressed as mean ± S.E.M,. Statistical analysis was performed using a two-way 
ANOVA and Tukey’s post-test, n=3, *p<0.05. 
 
Fig. 5 Increased serum TNFlevels and leukocyte infiltration of cardiovascular tissues are evident in 
aged animals. (A) TNF-α ELISA analysis of terminal sera samples taken from young and aged rats. 
Values are plotted as mean ± S.E.M, n=3 for young; n=4 for aged groups, *p<0.05. (B) Positive CD45 
staining in LV cardiac sections from (i) young and (ii) aged rats with (iii) histogram showing 
quantification (% CD45 positive cells). (C) Positive CD45 staining in aortic tissue from (i) young and (ii) 
aged rats with (iii) histogram showing quantification (% CD45 positive cells) in aorta. Images are shown 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 
21 
 
of each tissue at 40x magnification, and are representative of n=6 for both groups (scale bar = 100µm). 
Data was analysed using a student’s unpaired t test; n=6 for both groups, p<0.01**. 
 
Fig. 6 Endothelial cells isolated from aged aortae show altered phenotype. (A) Endothelial cells were 
successfully isolated from adult rat aorta and characterised by (i) PECAM-1 and (ii) v-WF staining. 
Panels (iii) and (iv) show positive staining of HUVECs for both markers respectively (positive controls). 
Panels (v) and (vi) show aortic endothelial cells stained with anti-rabbit or anti-mouse IgG-FITC 
secondary antibody alone respectively (negative control for both stains). (B) Representative images of 
aortic endothelial cells isolated from (i) young and (ii) aged rats and grown in culture for up to eight days 
(10x magnification). Images are representative of n=3 experiments, all at 10x magnification.  
 
Fig. 7 Pro-inflammatory signalling and oxidative stress are both significantly elevated in aged endothelial 
cells. (A(i)) Staining for basal phospho-p65 expression in young and aged aortic endothelial cells. TNFα -
stimulated young aortic endothelial cells served as a positive control. Where appropriate, cells were 
stimulated with TNFα (10ng/ml) for 10 min. Images are representative of n=3 for each condition and are 
shown at 10x magnification. (A(ii)) Quantification of pp65 signal intensity/cell was performed and data 
analysed using a one-way ANOVA followed by Tukey’s post-test; n=3 for each group; p<0.01**. (B) 
Histogram showing intracellular ROS production in young and aged endothelial cells with and without 
10µM Ang-II (3h) stimulation. Young cells treated with 50µM TBHP (3h) served as a positive control for 
the assay. All data are expressed as mean (a.u.) ± S.E.M. Statistical analysis was performed using a one-
way ANOVA and Tukey’s post-test, n=3 *p<0.05. 
 
Fig. 8 CaMKIIδ and ox-CaMKII expression are increased in aged aortic endothelial cells. (A) 
Representative images of young and aged endothelial cells stained for (i) total CaMKIIδ and (ii) ox-
CaMKII. Cells stained with secondary anti-rabbit IgG TRITC-conjugated antibody alone served as a 
negative control. Images are representative of n=3 experiments, all at 10x magnification (scale 100µm). 
(B) Immunoblot analysis of (i) CaMKIIδ and (ii) ox-CaMKII expression in young and aged aortic 
endothelial cells (~104 total cells). Data was normalised to intrinsic GAPDH expression and plotted as 
mean ± S.E.M in accompanying histograms, Data was analysed using a student’s unpaired t-test, n=4, 
*p<0.05, **p<0.01. 
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